Log in to save to my catalogue

End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tom...

End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tom...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2232073458

End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography

About this item

Full title

End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography

Publisher

New York: Nature Publishing Group US

Journal title

Nature medicine, 2019-06, Vol.25 (6), p.954-961

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

With an estimated 160,000 deaths in 2018, lung cancer is the most common cause of cancer death in the United States
1
. Lung cancer screening using low-dose computed tomography has been shown to reduce mortality by 20–43% and is now included in US screening guidelines
1

6
. Existing challenges include inter-grader variability an...

Alternative Titles

Full title

End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2232073458

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2232073458

Other Identifiers

ISSN

1078-8956

E-ISSN

1546-170X

DOI

10.1038/s41591-019-0447-x

How to access this item